共 50 条
Enteral and parenteral nutrition considerations in pediatric patients
被引:9
|作者:
Cober, Mary Petrea
[1
,2
]
Gura, Kathleen M.
[3
,4
]
机构:
[1] Akron Childrens Hosp, Dept Pharm, Akron, OH 44308 USA
[2] Northeast Ohio Med Univ, Rootstown, OH 44272 USA
[3] Boston Childrens Hosp, Dept Pharm, Boston, MA USA
[4] Harvard Med Sch, Boston, MA 02115 USA
关键词:
compounding;
enteral;
neonatal;
nutrition;
parenteral;
pediatric;
stability;
RESTING ENERGY-EXPENDITURE;
VITAMIN-D DEFICIENCY;
BODY-MASS INDEX;
NECROTIZING ENTEROCOLITIS;
CHILDHOOD OVERWEIGHT;
NEONATAL PATIENTS;
AMERICAN-SOCIETY;
ALUMINUM CONTENT;
PRETERM INFANTS;
AMINO-ACIDS;
D O I:
10.1093/ajhp/zxz174
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Purpose. Current clinical practice guidelines on management of enteral nutrition (EN) and parenteral nutrition (PN) in pediatric patients are reviewed. Summary. The provision of EN and PN in pediatric patients poses many unique considerations and challenges. Although indications for use of EN and PN are similar in adult and pediatric populations, recommended EN and PN practices differ for pediatric versus adult patients in areas such as selection of EN and PN formulations, timing of EN and PN initiation, advancement of nutrition support, and EN and PN goals. Additionally, provision of EN and PN to pediatric patients poses unique compounding and medication administration challenges. This article provides a review of current EN and PN best practices and special nutrition considerations for neonates, infants, and other pediatric patients. Conclusion. The provision of EN and PN to pediatric patients presents many unique challenges. It is important for pharmacists to keep current with pediatric- and neonatal-specific guidelines on nutritional management of various disease states, as well as strategies to address compounding and medication administration challenges, in order to optimize EN and PN outcomes.
引用
收藏
页码:1492 / 1510
页数:19
相关论文